cervical cancer
Cervical cancer experts campaign to increase screening rates and save lives
April 30, 2025Research and Development NHS, NHS England, Oncology, campaign, cervical cancer, screening
A coalition of experts fighting to end cervical cancer, referred to as the UK Consensus Group of the Advancing Cervical …
FDA approves Roche’s HPV self-collection screening option
May 15, 2024Medical Communications FDA, HPV, Oncology, Roche, cervical cancer
Roche has announced that the US Food and Drug Administration (FDA) has approved its human papillomavirus (HPV) self-collection solution. This …
Merck shares results for Keytruda in cervical cancer treatment
March 18, 2024Research and Development Merck, Oncology, cervical cancer, keytruda, women's health
Merck, known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-A18 trial, …
FDA approves Merck’s Keytruda with chemoradiotherapy as cervical cancer treatment
January 15, 2024Medical Communications FDA, Oncology, cervical cancer, keytruda
Merck, known as MSD outside of the US and Canada, has announced that the US Food and Drug Administration (FDA) …
Sanofi’s Libtayo shows positive Phase III results in advanced cervical cancer
May 13, 2021Libtayo, Sanofi, cemiplimab, cervical cancer
Regeneron Pharmaceuticals and Sanofi have announced today positive Phase III trial results investigating the PD-1 inhibitor Libtayo (cemiplimab) in patients …
Boys in UK to be given HPV vaccine
July 9, 2019Manufacturing and Production HPV, HPV vaccine, Vaccine, cervical cancer, oncology, pharma
Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …
Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations
June 27, 2019Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines
A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …
Battling cervical cancer in the developing world
June 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Doctors Without Borders, Medecins sans frontieres; cancer, cervical cancer, malawi, pharma
The non-profit humanitarian organization Medecins Sans Frontieres, or Doctors Without Borders, is well known for its work fighting on the …
HPV vaccine prevents 90% of cervical pre-cancer cases in Scotland, research shows
April 4, 2019Research and Development HPV, Scotland, cervical cancer, immunity, vaccines, virus
Routine vaccination of girls in Scotland against HPV has led to a dramatic drop in cases of cervical cancer, according …
UK cervical cancer screening rates fall to 21-year low
November 28, 2018Medical Communications, Research and Development Cancer, NHS, UK, cervical cancer, pharma
A report by NHS Digital has revealed that cervical cancer screening coverage has fallen to 71.4%, down from 72% in …
MedImmune and Inovio collaborate on cancer vaccine
August 11, 2015Manufacturing and Production, Research and Development AstraZeneca, HPV, Inovio, MedImmune, cancer vaccines, cervical cancer, oncology
MedImmune has entered into a license agreement and collaboration with Inovio, a biotechnology company developing DNA-based immunotherapies for cancer and …
FDA speedy review for new Avastin licence
July 16, 2014Research and Development, Sales and Marketing Cancer, Roche, avastin, cervical cancer
The FDA has granted priority review status for Roche’s Avastin (bevacizumab) plus chemotherapy in women with persistent, recurrent or metastatic …
Gardasil better value for money than Cervarix, finds new study
September 28, 2011Sales and Marketing Cervarix, Gardasil, HPV, cervical cancer
A new report by the Health Protection Agency has found that Gardasil is a more cost-effective vaccine for cervical cancer …
GSK-Merck back new developing world cancer charity
September 14, 2011Medical Communications Cancer, GSK, Merck & Co, Pink Ribbon-Red Ribbon, breast cancer, cervical cancer
GlaxoSmithKline and Merck are among the backers of a new charity that focuses on preventing female cancers in developing countries. …
Roche pulls out of vaccine alliance with Transgene
February 23, 2011Research and Development HPV, HPV vaccine, Roche, TG4001, Transgene, cervical cancer, cervical lesions, human papilloma virus, vaccines
Roche has terminated its license agreement with Transgene for its HPV therapeutic vaccine TG4001. The vaccine is currently being tested …
